Pfizer Inches Higher as Investors Await Quarterly Results
Pfizer shares ticked up modestly on Monday as investors prepared for the company's quarterly report due before markets open on Tuesday. Analysts anticipate a roughly 5% decline in revenue to about $16.95 billion and a 9.5% drop in adjusted EPS to $0.57 from $0.63 a year earlier. The drugmaker's recent guidance flagged tougher years ahead beginning …